Seizing Opportunities,
Scripting Success
Kopran Limited has established an indomitable presence in the realm of manufacturing an extensive spectrum of Active Pharmaceutical Ingredients (APIs) and Formulations.,
Our products have traversed borders and have found their way into more than 60 countries, including African nations, South Africa, the United States, Latin America, Southeast Asia, the European Union, China, Australia, CIS region and the United Kingdom. This global acceptance reflects our firm dedication to deliver excellence and ensure top-notch quality.
Our Competitiveness
R&D and state-of-the-art capabilities
Products with highest quality standard
Accreditations across all the continents
Experienced team
To create a sustainable growth business through integrated approach to product development, adoption of latest technologies and highest standards of quality and manufacturing practices. As a socially conscious organization, our endeavor is to provide medicines to people at affordable prices.
Creating a Positive and Productive Work Culture
Investor Zone
KPIs of FY 2024-25
Revenue
Rs. 61,459 Lakhs
EBITDA
Rs. 7,441 Lakhs
PAT
Rs. 5,096 Lakhs
Debt/Equity
0.17
Updates
- Unaudited Financial Results for the Quarter Ended 30th June, 2025.
- Investor Presentation Q4 FY 2024-25
- Annual Report 2024-25
- Business Responsibility & Sustainability Report for the FY 2024-25
- Integrated Governance 31st March, 2025
- Shareholding Pattern as on 31st March, 2025
- Notice of 66th AGM for FY 2024-25
Work Culture
